Remarkably, the four tumors that were initially suspected to be tRCC but lacked TFE3 fusion clustered with ccRCC, confirming that TFE3 fusion is a strong determinant of tRCC. The gene discussed is TFE3; the disease is nonpapillary renal cell carcinoma.